ArticleCancer research and treatment2017

Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program Cohort.

Minkyu Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.